Morgan Stanley lowered the firm’s price target on Healthpeak Properties (DOC) to $18 from $21 and keeps an Overweight rating on the shares after updating the firm’s 2026 and 2027 FFO estimates.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC: